Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.065 | 0.7 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |